Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: An Italian Collaborative Study from the 'Mario Negri' Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

A. Buda, I. Floriani, R. Rossi, N. Colombo, V. Torri, P. F. Conte, R. Fossati, A. Ravaioli, C. Mangioni

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: An Italian Collaborative Study from the 'Mario Negri' Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group'. Together they form a unique fingerprint.

Medicine & Life Sciences